Verastem (NASDAQ:VSTM) Now Covered by StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a report released on Thursday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.

Separately, HC Wainwright dropped their price target on shares of Verastem from $5.00 to $3.00 and set a “buy” rating on the stock in a research note on Monday, November 7th. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, Verastem currently has a consensus rating of “Moderate Buy” and a consensus price target of $5.00.

Verastem Price Performance

VSTM opened at $0.49 on Thursday. Verastem has a 12-month low of $0.29 and a 12-month high of $2.13. The company has a quick ratio of 4.97, a current ratio of 4.97 and a debt-to-equity ratio of 0.39. The firm has a market capitalization of $102.94 million, a P/E ratio of -1.26 and a beta of 0.81. The stock has a fifty day moving average of $0.55 and a 200-day moving average of $0.63.

Hedge Funds Weigh In On Verastem

Hedge funds have recently bought and sold shares of the business. Arete Wealth Advisors LLC acquired a new position in Verastem during the fourth quarter worth $7,748,120,000. Eaton Vance Management acquired a new position in Verastem during the first quarter worth $28,000. Mirabella Financial Services LLP acquired a new position in Verastem during the first quarter worth $36,000. Y Intercept Hong Kong Ltd acquired a new position in Verastem during the second quarter worth $30,000. Finally, XTX Topco Ltd acquired a new position in Verastem during the first quarter worth $37,000. 60.59% of the stock is owned by institutional investors and hedge funds.

About Verastem

(Get Rating)

Verastem, Inc is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.